Chemotherapy of trypanosomiasis: the potentiation of melarsoprol by concurrent difluoromethylornithine (DFMO) treatment
- 1 July 1988
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 82 (4), 572-573
- https://doi.org/10.1016/0035-9203(88)90512-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Trypanothione metabolism: a chemotherapeutic target in trypanosomatidsParasitology Today, 1987
- Necessity of antibody response in the treatment of African trypanosomiasis with α-difluoromethylornithineBiochemical Pharmacology, 1986
- Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-α-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trialTransactions of the Royal Society of Tropical Medicine and Hygiene, 1985
- Role of Antibody in the Elimination of Trypanosomes after DL-a-Difluoromethylornithine ChemotherapyJournal of Parasitology, 1983
- Polyamine Metabolism: A Potential Therapeutic Target in TrypanosomesScience, 1980
- MSb and MSbB in the Treatment of Sleeping Sickness due to Infection withTrypanosoma GambiensePathogens and Global Health, 1953